MLchartDataset catalogue

host dendritic cell vaccine-001 MSSM/BIIR

Term · Oncology and biomedicine · MLC-T-ONC-014163

A dendritic cell (DC) vaccine containing ex vivo expanded autologous DCs obtained from a patient with leukemia with potential immunostimulating activity. Upon reintroduction into the host, the host dendritic cell vaccine-001 MSSM/BIIR may stimulate the immune system to mount a leukemia-specific cytotoxic T lymphocyte (CTL) response.

Table 1. Record
IdentifierMLC-T-ONC-014163
FieldOncology and biomedicine
SynonymsMSSM/BIIR HDC Vax-001
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-014163",
  "term": "host dendritic cell vaccine-001 MSSM/BIIR",
  "field": "Oncology and biomedicine",
  "definition": "A dendritic cell (DC) vaccine containing ex vivo expanded autologous DCs obtained from a patient with leukemia with potential immunostimulating activity. Upon reintroduction into the host, the host dendritic cell vaccine-001 MSSM/BIIR may stimulate the immune system to mount a leukemia-specific cytotoxic T lymphocyte (CTL) response.",
  "synonyms": [
    "MSSM/BIIR HDC Vax-001"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/host-dendritic-cell-vaccine-001-mssm-biir/"
}

Record 8,625 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.